Royalty Pharma
RPRX
#621
Rank
โ‚น3.683 T
Marketcap
โ‚น6,406
Share price
-0.01%
Change (1 day)
83.33%
Change (1 year)

P/S ratio for Royalty Pharma (RPRX)

P/S ratio as of November 2026 (TTM): 15.1

According to Royalty Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.03. At the end of 2026 the company had a P/S ratio of 12.6.

P/S ratio history for Royalty Pharma from 2020 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202612.632.46%
20259.5343.34%
20246.65-7.06%
20237.15-8.2%
20227.794.23%
20217.48-18.32%
20209.15

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Abbott Laboratories
ABT
3.85-74.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
14.2-5.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
1.56-89.66%๐Ÿ‡บ๐Ÿ‡ธ USA